Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hope you get it. This should be much higher by end of the year, actually guessing by end of this quarter
That little birdie could be right. There is so much potential growth and it’s just around the corner. This is a company that has a product and it works and is FDA cleared. Trading way too cheaply in my opinion and could easily explode once the big orders start flowing in and I believe they will
210000 Was much higher a few years back but sold quite a few . Keeping the rest for better times ahead
Hoping to hear success on European partner with cash infusion . Waiting to hear on South American deal. Waiting to hear approved category code for treatments in United States . Waiting to hear feedback from all the offices that the device was placed as they have an option to keep or return the device based on satisfaction levels . If all the forces are positive then we are going much , much higher but there is still a big risk like an OTC stocks . However I like what I see
This stock is a little frustrating as I have been holding for some time and just watched it drop for the last year . News has been fine, other then lack of cash and pulling out of the South American deal with no explanation . Hope to hear new deals shortly to prop up finances and more reviews from the medical field relating to how good the product is for foot ulcers. Then we should really start to move. My biggest concern is cash and I would love to know more of how they are going to finance operations for the rest of the year with all the extra expenses of hiring a sales team and research and development . On that note I still believe we are close to finally becoming a profitable company
Actually just read it and I agree it was disappointing. Default on payments , tiny cash position and high expenses with low revenue. Need to hear some real revenue producing deals . We had the South American one fall through but don’t even know what we got from that . Seems like the other deals are not making the money I would have hoped. Obviously they are forced to partner in Europe as they develop US market .they could still achieve this however with great medical feedback and an insurance reimbursement code . Will listen carefully to the call tomorrow for positive signals. The price is still cheap compared to many other heavy loss making medical device companies
Have not seen the 10q. Was waiting for earnings call tomorrow to see where we stand . Still holding strong
Wish I had some extra cash to buy down here . Just seems so cheap for a company so close to profitability . Suppose I just need to hold and wait
Bunka talks about what great opportunities we have and how big the company is growing, yet releases small deals with little details. Yes he is being protective on deals to avoid price disclosure but we still need to know as investors if we are financially sound or need to dilute. What he needs to do is write a quick letter to shareholders talking about cash position and new developments . Still think this is a huge buy at these prices but very disappointed in the price action since the Altria deal. I really thought that would be the big turnaround
This hit 47 this time last year and we have seen no dilution , warrants have been cashed so we should see some nice upward movement soon
Wish I could. I bought a little at 18 but don’t have any extra cash to nibble sad to say but I am holding a decent position so just waiting knowing we are just growing each quarter and will be over a buck by years end. Just my guess based on growth , new sales and 2 international deals that I expect . I actually believe they could also announce a joint venture in the fracking side too. That would be a nice bonus
I am with you in some ways. Cut my position in half as frustrated by all the talk and no real results. If the Altria deal was not going to push us over 2, then I am at at loss to what will. Guessing a real money deal where we get 50 million investment from Altria. Still holding the rest and like this long term . Will add more under $1 as I still see us as underpriced . However have held this a long time with no real positive action
Probably a good bet despite the lousy action in this stock of late. Had a nice nice up on decent volume. I expect the same to happen again soon . Waiting to hear on new hires for us sales team and a new international deal with upfront payment.
This stock has me at a loss. I really thought the Altria deal would be the turning point . Despite only a million dollar investment it gave us huge credibility and the likelihood of a much bigger investment . Now a deal in California and I am sure many more to come. I keep looking at this and thinking what am I missing here . Since I cannot see it, I am going to hold and wait for what I think is to come . Much much higher pricing . It’s a question of when. I think patience will reward us well although it’s tough to have the way the stock price trades on news . Hoping the 8000 a month they pay the marketing firm pays dividends
Noticed they sent out a statement talking about promotions and increased volume. Not sure why unless legal recommended it. All they did was promote the company to try and give it more exposure. Very few investors know about Sanuwave and they need a few institutional investors here to change the scope of the stock
Offering probably filled and news forthcoming. Gives them cash in the bank for the time being. Great potential here but also high risk. I do think we see a buyout down the road as lung cancer is such a huge market and there is a real opportunity here. Day traders pushed this up. Don’t like the announcement of news forthcoming , then a capital raise. Not the type of thing a company that cares about it’s shareholders should do. Then again not many otcb stocks have any ethics
I agree. I did have 500k shares , but am down to 210k shares as needed some cash. However definitely holding these for a few years. It’s been a while in the making but we are finally at take off point
Nice push upwards on volume and then here we are back down at 19 cents again. Not sure what it will take to push this up and keep it up. Guessing a new international deal, joint venture deal and a few more United States device sales. Think all this will happen and my only concern is the need for more cash which may come from a joint venture soon to be announced
This undervalued gem is starting to get a little notice finally . Much more down the line . You won’t find many stocks trading at this price with FDA approval , worldwide contracts and about to expand into a huge USA market . Excited here
I do not understand this stock. Based on its potential and likelihood of a much bigger Altria investment we should be trading well north of $2 and that is just the beginning. All sorts of other deals in the making . This is a big hold 5 years and reap the huge rewards. Not easy based on the stock action but I still think this presents a huge win down the line.
Check out dailytrending stocks.com Nice article on Sanuwave . Potential huge. Finally trading over one million . That’s what we need . Volume
Must say I am disappointed in the action of this stock lately. Needs more recognition. I think people are worried about the financial side and necessary dilution. However the warrant situation covers us for a few more months, then I would like to see some serious cash numbers from a new partnership to tie us over as we start to approach profitability. It really is so close at hand after so many years in the making
Always up for a party. As soon as wee hit $1 I’m ready . I look at all reports on this company and really feel this could be a little gem in the making. The major legwork is done getting the approvals from the FDA , now need a few great reviews from the doctors offices that use the device and we will really soar. International deal close at hand for a bonus and hopefully a little cash infusion to help grow our United States operation
Yes I think it looks great. Real company with real hope of profitability unlike so many other otc stocks out there . Big international presence with more deals to come. Zacks just sent our a report valuing us at 85 cents conservately . New sales team hired. Once we get the insurer payment code for treatment approvals we should soar. This is a fast growing company with real potential to make lots of money here . Management are very open and honest and Mr Richardson has over delivered on all goals set to date. I believe this will continue
It amazes me this price action. We have an altar deal with great further potential . This alone should make us over 2 dollars a share and that is only the beginning. Need to just look away , hold and patiently wait. Never easy but still believe rewards will come
Indeed it was. Think I meant public recognition from doctors offices and hospitals . Cheers
Things are looking great here. Warrants should keep us financed until close to end of year to avoid dilution . By then we should be making a few good sales, getting an infusion of cash from new deals and expanding our tech ology . Also will have a code for insurance payments for treatments . Just need more pillbox recogniton . Hiring a new sales force validates the whole process . Good things ahead
Agreed. Have watched us drop from 64 cents to 14 cents over a year period and with all the positive news in place , it has to be concern of the cash position . No institutional here so guessing retail investors fear the same thing . Earnings on March 28 May ease this concern . Would like to avoid dilution by influx of cash from product growth . They are truly expanding as salesjobs posted throughout the country . Just need cash to pay for the expansion . Next year we should have plenty so need a short term fix
Agreed. Have watched us drop from 64 cents to 14 cents over a year period and with all the positive news in place , it has to be concern of the cash position . No institutional here so guessing retail investors fear the same thing . Earnings on March 28 May ease this concern . Would like to avoid dilution by influx of cash from product growth . They are truly expanding as salesjobs posted throughout the country . Just need cash to pay for the expansion . Next year we should have plenty so need a short term fix
One day soon I will look at this board and read congrats Kong’s on holding through this volatile period. .I see us as way undervalued and a potential blockbuster stick sooner rather then later. Way too much potential here to worry . Altria saw it and they are just beginning with us. Much more to follow if you can sit and hold without stressing daily non movement awaiting the bigger news to come
I think they will come soon. Earnings out March 28 . Hoping for more positive news as always. Feel we are on the cusp of something big with a code for treatments meaning big revenues by next year. This year will be fair but next year will be superb
To be honest. Instinct. I just feel that something good is close at hand. Risky otc stock so my due diligence tells me that they have a viable product that works and is growing fast. Can’t sat that about the majority of otc stocks. Looking forward to quarterly report if only I could find out when it will be announced
Agreed that pumping can be a prelude to a cash raise but I did buy more today as still think we have a great future here. Like the risk/reward at this low market value
Because every stock I know looks to promote its benefits .i totally get your frustration however as it’s been a pretty lousy 6 months of nothing. Need real revenue news before things change
Seems like you have lost the faith in Sanuwave. These articles are still positive and do point to many specifics as to why I bought the stock . I have 200k and actually think we will be over a buck by years end. Looking for earnings in he next few days to substantiate my claim. Yes, cash position is very important as is revenue stream as this avoids the dreaded and famed OTC dilution. We do have a product and it does work . We have a worldwide presence and a good management team so I have to believe our future looks great
It is my personal belief that Lexaria will one day be a multi billion dollar company . Vast potential in beverage , nicotine and food can reward us with many more partnerships like Altria and hill street. Altria will eventually invest far more as the smoking law suits have escalated lately and I expect news on new partnerships that have been made and are still to be announced.. This company is a screaming buy at current price. Just my opinion , but I love the potential here. So much garbage on the OTC that is based on lies and hype . I think this is a real gem and the one in a 1000 that actually make it big. Staying patient here
We have a stock with such huge potential in LXRP. I know it’s slow moving, but I really feel we will explode in the next two years. This is a buy and hold for fantastic returns . The technology is unique and deals like Altria are just the beginning. Watch for many more partnerships this year and real revenue that will ease the dreaded fear we all have of dilution . I see so many positives in the company, with the only concern being required cash. I do believe the Altria deal will amount to much more then the paltry one million investment
Agreed , but it’s still good to hear the positives. I think earnings will be out early March and we will really see how we are doing . Still think we have a good company and this has the potential to go much higher then current levels.
Obviously the newsletter to shareholders was a positive as it shows the companies direction . I do wish they talked a little about cash flow and financing operations to ensure no dilution . I still think we have a good year in 2019 and an amazing year in 2020 once all codes are established and this device becomes the Norm in doctors offices. Exciting times but always risk like all penny stocks .
I agree. Cash is a concern. Don’t mind international growth if it brings in cash. They have been losing money for a long time and I think this could be the year we turn the corner . Only hoping that they avoid dilution in the process . Think they will but still worried . I actually love the device as it has so much usage for so many issues from strains and sprains to foot ulcers and plantar facitas etc. even the fracking issue could become something soon enough